IFRX (inflarx.de) Sof foyda

IFRX (inflarx.de) - kompaniyaning tovar belgisi

InflaRx N.V. (IFRX) o'zining noyob Gohibic dori vositasi tufayli shoshilinch tibbiyot sohasida ustunlikka ega bo'lib, bu unga sezilarli narx belgilash imkoniyatini beradi. Kompaniyaning xodimlar siyosati yetakchi nemis immunologlarini jalb qilishga asoslangan. Ushbu grafikdagi kompaniyaning sof operatsion foydasi moliyaviy barqarorlikni namoyish etadi, bunda 0.00 ko'rsatkichning joriy darajasidir. Texnologik rivojlanish yangi terapevtik molekulalarni qidirishni avtomatlashtirish uchun laboratoriya robototexnikasini joriy etishga asoslangan.

IFRX (InflaRx N.V.) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

inflarx.de (IFRX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari InflaRx|IFRX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi IFRX|IFRX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati InflaRx|IFRX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi inflarx.de|IFRX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati InflaRx N.V.|IFRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati InflaRx|IFRX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar IFRX|IFRX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi InflaRx|Shoshilinch likvidlik inflarx.de
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
IFRX - Sof foyda
Kompaniyaning jamlanma tahlili:InflaRx N.V.
InflaRx NV asosiy tovari

Ushbu ko'rsatkich kunlik sof daromadni kuzatib boradi, bu esa savdo hajmlariga tayanmasdan uzoq muddatli tendentsiya barqarorligini va kapitalning kamayish ehtimolini aniqlash imkonini beradi. Kompaniyaning ortiqcha daromadlarini tahlil qilish orqali investor biznesning real daromadliligini baholaydi, bunda InflaRx N.V. (IFRX) ning tartibga solingan ekologik laboratoriya tozalash uchun standart xarajatlari ham yakuniy foyda dinamikasida aks etadi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniya foydasi UPB|ZBIO (Zenas Biopharma) - Sof foyda|Immunome Inc - Soliqdan keyingi foyda|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|Kompaniyaning sof foydasi KALV (KalVista Corp)|Sof foyda SEPN (Septerna Inc)|Sof foyda pieris.com PVLA|SVRA - Kompaniyaning sof foydasi|Yakuniy foyda RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Sof daromad|Kompaniya foydasi ATXS|Sof daromad ENGN|RAPT: Yakuniy foyda|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|Aclaris Therapeutics Inc. - Kompaniya foydasi|Kyverna - Sof daromad|Sof moliyaviy natija Tiziana Life Sciences, Ltd. (TLSA)|CABA: Sof daromad|VTYX: Kompaniyaning sof foydasi|THTX (Theratechnologies) - Sof daromad|AVTX - Sof moliyaviy natija|ELDN (Eledon) - Sof foyda|Agenus, Inc (AGEN) - Sof moliyaviy natija|Sof foyda CLYM|ZURA: Soliqdan keyingi foyda|Kompaniyaning sof foydasi aTyr Pharma ATYR|Yakuniy foyda ADAG|IMA: Sof daromad|STTK (Shattuck Labs, Inc.) - Kompaniya foydasi|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Sof foyda|ATRA: Yakuniy foyda|Sof foyda XFOR|Sof foyda adicetbio.com (ACET)|Kompaniyaning sof foydasi Celularity CELU|Yakuniy foyda INMB|BRNS - Kompaniyaning sof foydasi|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Sof daromad ENLV|QTTB: Yakuniy foyda|Sof foyda GOVX|Sof moliyaviy natija Edesa Biotech Inc|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|HCWB (hcwbiologics.com) - Sof daromad|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Kompaniya foydasi ADTX (Aditxt Corp)|Sof foyda GRI|XRTX - Kompaniyaning sof daromadi|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|SCNI (BiondVax Pharmaceuticals) - Kompaniya foydasi|CALI: Sof foyda|Soliqdan keyingi foyda AFMD (Affimed N.V.)|Kompaniyaning sof foydasi Allakos Inc|Kompaniyaning sof foydasi HOOK|Sof foyda IGMS|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|Yakuniy foyda TCBP|THRD: Sof daromad